phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
Published 1 year ago • 147 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
3:06
phase i study of hpn217 in patients with r/r multiple myeloma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:05
updated phase i results from sgnbcma-001 study of sea-bcma in patients with r/r multiple myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
0:59
defining the origins of multiple myeloma
-
52:32
spm biology: sbp trial (paper 1) 2022 l latest format!
-
9:25
mgus diagnosis: a step-by-step approach
-
6:15
usmle® step 1 high yield: immunology, hematology, and oncology: hemostais animation
-
2:46
managing patients with high-risk myeloma
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:20
first-in-human study of tak-169 in r/r mm
-
3:38
outcomes for patients with multiple myeloma who have had first-line monoclonal antibody exposure
-
2:44
myeloma qol through induction and maintenance
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
2:27
horizon scan of car-t in multiple myeloma
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma